These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9401486)

  • 21. Two objective "archivable" tests for voluntary muscle testing in ulnar and median nerve paralysis.
    Bourrel P
    Indian J Lepr; 1997; 69(1):13-23. PubMed ID: 9142539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactions and their management.
    Ganapati R; Pai VV
    J Indian Med Assoc; 2004 Dec; 102(12):688-90, 692, 694. PubMed ID: 15871353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis.
    Wilder-Smith A; Wilder-Smith E
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):20-7. PubMed ID: 9207750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery of common paralytic conditions.
    Duerkson F
    Lepr Rev; 1998 Dec; 69(4):390-6. PubMed ID: 9927812
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of epicondylectomy in early ulnar neuritis treated with steroids.
    Pannikar VK; Ramprasad S; Reddy NR; Andrews P; Ravi K; Fritschi EP
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):501-5. PubMed ID: 6535823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Median nerve function after tendon transfer for ulnar paralysis.
    Brandsma JW; Brand PW
    J Hand Surg Br; 1985 Feb; 10(1):30-2. PubMed ID: 3998598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.
    Wagenaar I; Brandsma W; Post E; van Brakel W; Lockwood D; Nicholls P; Saunderson P; Smith C; Wilder-Smith E; Richardus JH
    BMC Neurol; 2012 Dec; 12():159. PubMed ID: 23249098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, randomized trial for use of prednisolone in patients with facial nerve paralysis after parotidectomy.
    Roh JL; Park CI
    Am J Surg; 2008 Nov; 196(5):746-50. PubMed ID: 18757050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
    Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
    Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
    Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of sensibility in irreparable ulnar and median nerve lesions with use of sensory nerve transfer: long-term follow-up of 20 cases.
    Ozkan T; Ozer K; Gülgönen A
    J Hand Surg Am; 2001 Jan; 26(1):44-51. PubMed ID: 11172367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of ocular side effects of pulse steroid therapy versus long-term oral steroid therapy in steroid responsiveness dermatoses.
    Dogra A; Jain M; Bajwa GS; Aggarwal A
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):213-4. PubMed ID: 12483972
    [No Abstract]   [Full Text] [Related]  

  • 34. An attempt towards prevention and management of disabilities and deformities in leprosy.
    Husain S
    Indian J Lepr; 2011; 83(1):9-14. PubMed ID: 21638978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tendon transference for ulnar and combined ulnar-median nerve paralysis.
    Skielboe BE; Koh JY
    Acta Orthop Scand; 1965; 36(2):137-52. PubMed ID: 5829695
    [No Abstract]   [Full Text] [Related]  

  • 37. A two-tendon transplant for low median-ulnar palsy of the thumb in leprosy.
    Price EW
    Proc R Soc Med; 1968 Mar; 61(3):220-3. PubMed ID: 5645955
    [No Abstract]   [Full Text] [Related]  

  • 38. The severely deformed foot in leprosy. Causation, prevention and treatment.
    Fritschi E
    Int J Lepr Other Mycobact Dis; 1971; 39(2):618-26. PubMed ID: 4401961
    [No Abstract]   [Full Text] [Related]  

  • 39. Electromyographic evaluation of therapeutic methods in complete peripheral paralysis. A preliminary communication of the Belgian Society of Physical Medicine and Rehabilitation.
    Rosselle N; Schellens L; Ghesquiere F; Diniz P; Geerinckx P; DE Meirsman J
    Electromyogr Clin Neurophysiol; 1974; 14(5-6):549-52. PubMed ID: 4549045
    [No Abstract]   [Full Text] [Related]  

  • 40. Missile-caused median nerve injuries: results of 81 repairs.
    Roganovic Z
    Surg Neurol; 2005 May; 63(5):410-8; discussion 418-9. PubMed ID: 15883059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.